|
| 37754493 | <i>Helicobacter pylori</i> Status May Differentiate Two Distinct Pathways of Gastric Adenocarcinoma Carcinogenesis. | Curr Oncol | 2023 |
| 35174071 | Investigating Urinary Circular RNA Biomarkers for Improved Detection of Renal Cell Carcinoma. | Front Oncol | 2022 |
| 35818933 | A novel methylated cell-free DNA marker panel to monitor treatment response in metastatic prostate cancer. | Epigenomics | 2022 |
| 35151601 | Combining CAPRA-S With Tumor IDC/C Features Improves the Prognostication of Biochemical Recurrence in Prostate Cancer Patients. | Clin Genitourin Cancer | 2022 |
| 33758253 | Distinct DNA methylation patterns associated with treatment resistance in metastatic castration resistant prostate cancer. | Sci Rep | 2021 |
| 31161221 | Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome. | J Natl Cancer Inst | 2020 |
| 32081560 | A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade. | Urol Oncol | 2020 |
| 33008340 | A 38-gene model comprised of key TET2-associated genes shows additive utility to high-risk prostate cancer cases in the prognostication of biochemical recurrence. | BMC Cancer | 2020 |
| 32867540 | Dynamics of the cell-free DNA methylome of metastatic prostate cancer during androgen-targeting treatment. | Epigenomics | 2020 |
| 32420197 | Urinary biomarkers in prostate cancer: to the miRnome and beyond. | Transl Androl Urol | 2020 |
| 32153047 | Development of a multivariable risk model integrating urinary cell DNA methylation and cell-free RNA data for the detection of significant prostate cancer. | Prostate | 2020 |
| 31558364 | An integrative DNA methylation model for improved prognostication of postsurgery recurrence and therapy in prostate cancer patients. | Urol Oncol | 2020 |
| 31605802 | Methylation Markers in Prostate Biopsies Are Prognosticators for Late Biochemical Recurrence and Therapy after Surgery in Prostate Cancer Patients. | J Mol Diagn | 2020 |
| 30763230 | Are there differences between de novo and secondary upper tract urothelial carcinoma tumours? | Can Urol Assoc J | 2019 |
| 31200836 | GBX2 Methylation Is a Novel Prognostic Biomarker and Improves Prediction of Biochemical Recurrence Among Patients with Prostate Cancer Negative for Intraductal Carcinoma and Cribriform Architecture. | Eur Urol Oncol | 2019 |
| 30777394 | Combining urinary DNA methylation and cell-free microRNA biomarkers for improved monitoring of prostate cancer patients on active surveillance. | Urol Oncol | 2019 |
| 30917865 | Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression. | Clin Epigenetics | 2019 |
| 30801051 | epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer. | JCO Precis Oncol | 2019 |
| 29246734 | Assessment of Serum microRNA Biomarkers to Predict Reclassification of Prostate Cancer in Patients on Active Surveillance. | J Urol | 2018 |
| 30470249 | A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer. | Clin Epigenetics | 2018 |
| 29409465 | Association of rs2282679 A>C polymorphism in vitamin D binding protein gene with colorectal cancer risk and survival: effect modification by dietary vitamin D intake. | BMC Cancer | 2018 |
| 29428633 | Re: Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance: F. Zhao, E. Olkhov-Mitsel, T. van der Kwast, J. Sykes, D. Zdravic, V. Venkateswaran, A. R. Zlotta, A. Loblaw, N. E. Fleshner, L. Klotz, D. Vesprini and B. Bapat J Urol 2017;197:335-341. | J Urol | 2018 |
| 27545574 | Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance. | J Urol | 2017 |
| 28167242 | Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer. | Transl Oncol | 2017 |
| 28304185 | Modulation of transcription factor binding and epigenetic regulation of the MLH1 CpG island and shore by polymorphism rs1800734 in colorectal cancer. | Epigenetics | 2017 |
| 28293327 | The dynamic DNA methylation landscape of the <i>mutL homolog 1</i> shore is altered by <i>MLH1</i>-93G>A polymorphism in normal tissues and colorectal cancer. | Clin Epigenetics | 2017 |
| 28376164 | Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer. | J Natl Cancer Inst | 2017 |
| 28693181 | Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumors. | Oncol Lett | 2017 |
| 28765616 | Vitamin D receptor and calcium-sensing receptor polymorphisms and colorectal cancer survival in the Newfoundland population. | Br J Cancer | 2017 |
| 26981160 | Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis. | Clin Epigenetics | 2016 |
| 27404348 | Metformin Elicits Antitumor Effects and Downregulates the Histone Methyltransferase Multiple Myeloma SET Domain (MMSET) in Prostate Cancer Cells. | Prostate | 2016 |
| 26884349 | Promoter methylation of ITF2, but not APC, is associated with microsatellite instability in two populations of colorectal cancer patients. | BMC Cancer | 2016 |
| 27091807 | Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment. | Ann Oncol | 2016 |
| 25587051 | Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history. | Cancer Epidemiol Biomarkers Prev | 2015 |
| 25421657 | Beyond the island: epigenetic biomarkers of colorectal and prostate cancer. | Methods Mol Biol | 2015 |
| 25431236 | Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications. | Mod Pathol | 2015 |
| 24362816 | Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database. | Nat Genet | 2014 |
| 26461579 | [Not Available]. | Prog Urol | 2014 |
| 25277202 | Integrated analysis of epigenomic and genomic changes by DNA methylation dependent mechanisms provides potential novel biomarkers for prostate cancer. | Oncotarget | 2014 |
| 24880661 | FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer. | Virchows Arch | 2014 |
| 24651255 | Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids. | Sci Rep | 2014 |
| 24311408 | Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression. | Prostate | 2014 |
| 22883484 | Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. | Eur Urol | 2013 |
| 23549870 | Altered DNA methylation landscapes of polycomb-repressed loci are associated with prostate cancer progression and ERG oncogene expression in prostate cancer. | Clin Cancer Res | 2013 |
| 21721000 | Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries. | Cancer | 2012 |
| 23240038 | MLH1 region polymorphisms show a significant association with CpG island shore methylation in a large cohort of healthy individuals. | PLoS One | 2012 |
| 23342273 | Strategies for discovery and validation of methylated and hydroxymethylated DNA biomarkers. | Cancer Med | 2012 |
| 22966878 | Vitamin D intake is negatively associated with promoter methylation of the Wnt antagonist gene DKK1 in a large group of colorectal cancer patients. | Nutr Cancer | 2012 |
| 22702366 | Epigenetic biomarkers in colorectal cancer diagnostics. | Expert Rev Mol Diagn | 2012 |
| 22854115 | Lynch syndrome in a predominantly Afrocentric population: a clinicopathological and genetic study. | Can J Surg | 2012 |